David E. Cohen - 01 Jul 2021 Form 4 Insider Report for Timber Pharmaceuticals, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 01 Jul 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jul 2021, 16:06:16 UTC
Prior SEC filing: 13 May 2021
Next SEC filing: 09 Nov 2021
Source filing: View source filing
Reporting owner signature: /s/ Joseph Lucchese, Power of Attorney

Key filing fact

David E. Cohen filed Form 4 for Timber Pharmaceuticals, Inc. on 06 Jul 2021.

Key facts

This page summarizes David E. Cohen's Form 4 filing for Timber Pharmaceuticals, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Jul 2021, 16:06.

Change

Previous filing in this sequence was filed on 13 May 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TMBR transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +71,893
Change %
Price: $0.000000
Shares after: 71,893
Date: 01 Jul 2021
Ownership: Direct
Underlying class: Common Stock, par value $0.001 per share
Underlying amount: 71,893
Exercise price: $1.18
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The option grant was approved by the compensation committee of the board of directors of Timber Pharmaceuticals, Inc. (the "Company") on April 21, 2021, subject to stockholder approval of an amendment to the Company's 2020 Omnibus Equity Incentive Plan (the "Amendment"). The Company's stockholders approved the Amendment on July 1, 2021.

Footnote F2

The option grant will vest in 24 equal monthly installments beginning on August 1, 2021.